Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Predictmedix AI Inc (QB) | PMEDF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0174 | 0.0174 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.0104 - 0.1009 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.0174 | USD |
Predictmedix AI Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.01M | 145.65M | - | 35k | -2.07M | -0.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Predictmedix AI (QB) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PMEDF Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0111 | 0.0188 | 0.0104 | 0.0157966 | 29,167 | 0.0063 | 56.76% |
1 Month | 0.01755 | 0.02075 | 0.0104 | 0.0145319 | 67,461 | -0.00015 | -0.85% |
3 Months | 0.0377 | 0.0421 | 0.0104 | 0.0208113 | 40,752 | -0.0203 | -53.85% |
6 Months | 0.0383 | 0.06 | 0.0104 | 0.0273391 | 26,277 | -0.0209 | -54.57% |
1 Year | 0.09505 | 0.1009 | 0.0104 | 0.0512975 | 25,832 | -0.07765 | -81.69% |
3 Years | 0.2844 | 0.33 | 0.0104 | 0.095376 | 24,786 | -0.267 | -93.88% |
5 Years | 0.253 | 0.8648 | 0.0104 | 0.3368164 | 50,218 | -0.2356 | -93.12% |
Predictmedix AI (QB) Description
Predictmedix Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry. Predictmedix Inc. is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer's disease. |